Micrus' ACT MicroCoil Aimed At Target Therapeutics' Embolization Market
This article was originally published in The Gray Sheet
Executive Summary
Micrus Corp. is hoping that data from upcoming clinical trials of the ACT MicroCoil delivery system will demonstrate superiority to Target Therapeutics' Guglielmi Detachable Coil.